We specialize in hard to find items
All Categories
Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, Fourth Edition
Share Tweet
*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
- Electrical items MAY be 110 volts.
- 7 Day Return Policy
- All products are genuine and original
About Molecular Neuropharmacology: A Foundation For
Product Description The definitive guide to treating neurologic and psychiatric disorders with drugs and other approaches Doody's Core Titles for 2021! Fully updated with the latest research and drugs, Nestler, Hyman, & Malenka’s Molecular Neuropharmacology, Fourth Edition, is the leading guide to molecular neuroscience. Providing an in-depth look at the neuropharmacological fundamentals of the nervous system, it delivers the knowledge and insight you need to master the pathophysiology of neurologic and psychiatric disorders. Complete with tables, diagrams, and figures clearly illustrating the intricacies of neurochemistry and molecular neuroscience, this peerless guide reviews the effects of drug action (organized by drug category) to enhance your understanding of major disease mechanisms, and it explains the pathophysiology and neuropharmacology of all major neurologic and psychiatric disorders. Concise overviews of the effects of drugs and other treatment approaches are presented in a way that boosts your understanding and retention of critical concepts. Nestler, Hyman, & Malenka’s Molecular Neuropharmacology provides a deep dive into: General principles of neurophar¬macology Nervous system function Drugs that act on neuronal and glial function Major neurotrans¬mitter systems in the brain and spinal cord Atypical neurotransmitters, including peptides, growth factors, and cytokines Major brain and spinal cord systems at the molecular, cellular, and circuit levels in health and disease From the Publisher Eric J. Nestler, MD, PhD, is Dean for Academic and Scientific Affairs; Nash Family Professor of Neuroscience; and Director of the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai. Paul J. Kenny, PhD, is Director, Drug Discovery Institute, and Professor and Chair of Neuroscience at the Icahn School of Medicine at Mount Sinai. Scott J. Russo, PhD, is Professor of Neuroscience and Director of the Center for Affective Neuroscience at the Icahn School of Medicine at Mount Sinai. Anne Shaefer, MD, PhD, is Associate Professor of Neuroscience and Psychiatry and a Seaver Fellow at the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai. About the Author Eric J. Nestler, MD, PhD, is Dean for Academic and Scientific Affairs; Nash Family Professor of Neuroscience; and Director of the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai. Paul J. Kenny, PhD, is Director, Drug Discovery Institute, and Professor and Chair of Neuroscience at the Icahn School of Medicine at Mount Sinai. Scott J. Russo, PhD, is Professor of Neuroscience and Director of the Center for Affective Neuroscience at the Icahn School of Medicine at Mount Sinai. Anne Shaefer, MD, PhD, is Associate Professor of Neuroscience and Psychiatry and a Seaver Fellow at the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai. Robert C. Malenka, MD, PhD is Pritzker Professor of Psychiatry & Behavioral Sciences at Stanford University, Palo Alto, CA. He is a fellow of the American Academy of Arts and Sciences, a member of the Institute of Medicine of the National Academies and an Associate of the Neurosciences Research Program. He has won several awards including the International Prize in Neuroscience, the Distinguished Alumni Award from Stanford University and the Daniel Efron Award from the American College of Neuropsychopharmacology. A major goal of his laboratory is to elucidate both the specific molecular events that are responsible for the triggering of these various forms of synaptic plasticity and the exact modifications in synaptic proteins that are responsible for the observed, long-lasting changes in synaptic efficacy. Steven E. Hyman, MD is Provost of Harvard University and Professor of Neurobiology at Harvard Medical School, Boston, MA. From 1996 to 2001, he served as Director of the National Institute of Mental Health (NIMH), the component of the US National Institutes o
